Scientific Online Resource System

Scripta Scientifica Medica

Relapsing polychondritis. A case report and brief introduction to the disease

Filka Georgieva, Sonya Marina

Abstract

Relapsing polychondritis (RP) is a rare immune-mediated disease that occurs with recurrent inflammatory processes in cartilage structures and tissues rich in proteoglycans throughout the body, in particular the ears, nose, eyes, and joints. The long time between relapses makes diagnosis difficult and often the disease remains unrecognized. We present a case of a 56-year-old patient diagnosed with RP. The diagnosis is based on clinical indicators: polyarthritis, chondritis on ear cartilage, and good response to corticosteroid treatment.


Keywords

relapsing polychondritis, rare disease, erysipelas-like inflammation

Full Text


References

Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Inn Med. 1923; 6:93–100.

Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960;263:51–8. doi: 10.1056/NEJM196007142630201.

Horváth A, Páll N, Molnár K, Kováts T, Surján G, Vicsek T, et al. A nationwide study of the epidemiology of relapsing polychondritis. Clin Epidemiol. 2016; 8:211–30.doi: 10.2147/CLEP.S91439.

Borgia F, Giuffrida R, Guarneri F, Cannavò SP. Relapsing polychondritis: An updated review. 2018. Biomedicines;6(3):84. doi: 10.3390/biomedicines6030084.

Papo T, Wechsler B, Bletry O, Piette AM, Godeau P, Piette JC. Pregnancy in relapsing polychondritis: Twenty-five pregnancies in eleven patients. Arthritis Rheum. 1997;40(7):1245–9.doi: 10.1002/1529-0131(199707)40:7<1245::AID-ART8>3.0.CO;2-#.

Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 1993; 36(5):660–4.doi: 10.1002/art.1780360513.

Berger R. Polychondritis resulting from intravenous substance abuse. Am J Med. 1988; 85(3):415-7.doi: 10.1016/0002-9343(88)90597-9.

Vitale A, Sota J, Rigante D. Lopalco G, Molinaro F, Messina M, Iannone F, et al. Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives. Curr Rheumatol Rep. 2016;18(1):3. doi: 10.1007/s11926-015-0549-5.

Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978; 299(22):1203–7.doi: 10.1056/NEJM197811302992202.

Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, et al. Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev. 2010;9(8):540–6. doi: 10.1016/j.autrev.2010.02.016.

Buckner JH, Wu JJ, Reife RA, Terato K, Eyre DR. Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. Arthritis Rheum. 2000; 43(4):939–43.doi: 10.1002/1529-0131(200004)43:4<939::AID-ANR28>3.0.CO;2-Z. –

Longo L, Greco A, Rea A, Lo Vasco VR, De Virgilio A, De Vincentiis M. Relapsing polychondritis: a clinical update. Autoimmun Rev. 2016;15(6):539–43.doi: 10.1016/j.autrev.2016.02.013.

Moon, SY, Lee JA, Joung MK, Chung DR, Song JH, Peck KR. Nasal deformity due to tuberculous chondritis. Clin Exp Otorhinolaryngol. 2014;7(3):229–31.doi: 10.3342/ceo.2014.7.3.229.

Sharma A, Law AD, Bambery P, Sagar V, Wanchu A, Dhir V, et al. Relapsing polychondritis: clinical presentations, disease activity and outcomes. Orphanet J Rare Dis. 2014; 9:198. doi: 10.1186/s13023-014-0198-1.

Michet CJ, Post TW, editors, Clinical manifestations of relapsing polychondritis. Waltham, MA: UpToDate; 2018.

Francès C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC. Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore). 2001;80(3):173–9. doi: 10.1097/00005792-200105000-00003.

Ludvigsson JF, van Vollenhoven R. Prevalence and comorbidity of relapsing polychondritis. Clin Epidemiol. 2016;8:361–2.doi: 10.2147/CLEP.S121272.

Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, et al.Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000788. doi: 10.1136/rmdopen-2018-000788.

www.RPDAI.org




DOI: http://dx.doi.org/10.14748/ssm.v51i3.6127

Refbacks

About The Authors

Filka Georgieva
Medical University of Varna

Department of Infectious Diseases, Parasitology and Dermatovenereology, Faculty of Medicine

Sonya Marina
Medical University of Varna
Bulgaria

Department of Infectious Diseases, Parasitology and Dermatovenereology, Faculty of Medicine

Font Size


|